A medical firm in Hartlepool is expanding into a new building and taking on new staff as it houses the firm’s research and development team.
Hart Biologicals, who specialise in making the reagents which are used to investigate the blood clotting function in patients, are taking over a vacant 6,500 sq ft unit next to its headquarters.
The managing director of Hart Biologicals, Alby Pattison, said the expansion is in link with the development of partner organisations that his team works with.
He said: “This expansion is in response to the continued growth of the business, and we are delighted to have been able to take over the vacant premises next door to our base.
“The current site will be our manufacturing hub, and we have reconfigured it all to house the R&D team next door.
“Sharing labs and office space has not been ideal as we have grown as a business in recent years, so this really is the next stage of our development.”
The firm worked closely with Tees Valley Unlimited to secure Regional Growth Fund investment, with Hartlepool Borough Council and the North East Chamber of Commerce amongst the groups having a positive input which will enable the firm to expand.
Mr Pattison added: “We finalised the bid in September last year, so it has been quite a quick process once the funding was secured.”
As part of the expansion the firm will create 13 new positions over the next two and a half years, with roles to be filled at various levels including research and development scientists.